KIT2014

DRUG2 trials

Sponsors

Kither Biotech Srl

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis

Phase 1

A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects

CompletedNCT06659757

Kither Biotech SrlCystic Fibrosis

Start: 2024-10-16End: 2025-07-14Updated: 2025-08-05

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

RecruitingNCT07668518

Kither Biotech SrlChronic Obstructive Pulmonary Disease (COPD)

Start: 2026-08-05End: 2027-07-31Target: 36Updated: 2026-09-09